Guardant Health is taking its FDA-approved Shield™ blood test for colorectal cancer into senior living communities through a new partnership with LabFlorida. Instead of invasive colonoscopies or stool kits, residents can now be screened with a simple blood draw—making early detection far more accessible for a population at highest risk. With millions of seniors still missing routine screenings, will this move redefine how preventive cancer care is delivered to aging Americans?
Guardant Health Expands Access to Shield CRC Blood Test to Senior Living Communities with LabFlorida Partnership (Business Wire)
0